Paulino Goco, MD
Otolaryngology · Murfreesboro, TNNPI 1346288933
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by AbbVie at 44.2% of the total. Among otolaryngology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $45.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Stryker$3K
- Sanofi$523
- Aerin Medical Inc.$464
- Inspire Medical Systems, Inc.$441
- Optinose US, Inc.$416
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$5,08342%
- Food & beverage$6,84057%
- Education$901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 71 | $5,313 |
| Stryker | 79 | $3,135 |
| Sanofi | 19 | $523 |
| Aerin Medical Inc. | 5 | $464 |
| Inspire Medical Systems, Inc. | 10 | $441 |
| Optinose US, Inc. | 18 | $416 |
| Regeneron Healthcare Solutions, Inc. | 14 | $409 |
| GSK | 21 | $393 |
| Biotissue Holdings Inc. | 2 | $263 |
| Medtronic | 3 | $151 |
| Revance Therapeutics, Inc. | 2 | $116 |
| Hologic Sales And Service, LLC | 2 | $47 |
| Smith+Nephew | 1 | $35 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Amgen | 1 | $34 |
| Olympus America Inc. | 2 | $27 |
| Acclarent, Inc | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $24 |
| Neurent Medical Limited | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Alk-abello, Inc | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $13 |
| Intersect ENT, Inc. | 1 | $12 |
| Xoran Technologies LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPRESS ENT DILATION SYSTEM$521
- ENTELLUS - XPRESS ENT DILATION SYSTEM$502
- VIVAER STYLUS$352
- RHINAER STYLUS$352
- NEOX$263
- CLARIX$263
- Inspire$260
- CMI$161
- Actishield$123
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$101
- DAXI$101
How this compares
$12,014 in reported general payments places this provider in the 90th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 13 | $48,910 |
| Famotidine | 552 | $9,255 |
| Azelastine Hcl | 102 | $3,323 |
| Liothyronine Sodium | 61 | $2,667 |
| Fluticasone Propionate | 115 | $1,463 |
| Ipratropium Bromide | 32 | $1,188 |
| Np ThyroidThyroid,pork | 11 | $1,169 |
| Levothyroxine Sodium | 102 | $653 |
| Montelukast Sodium | 62 | $619 |
| Omeprazole | 63 | $584 |
| Mometasone Furoate | 13 | $534 |
| Pantoprazole Sodium | 18 | $491 |
| Scopolamine | 12 | $415 |
| Azithromycin | 35 | $270 |
| Doxycycline Hyclate | 23 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $393 | $48,91013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 191 otolaryngology providers in Tennessee.
Other otolaryngology in Murfreesboro
- Britni CaplinMurfreesboro$4K
- James FordiceMurfreesboro$4K
- Brannon MangusMurfreesboro$3K
- George ConverseMurfreesboro$3K
- Rakesh ChandraNashville$381K
- David FortuneHermitage$298K
- Grady BryantHermitage$74K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.